Form 4: FibroGen SVP Christine Chung Reports Stock Transactions

Christine Chung, SVP of China Operations at FibroGen, reported the acquisition and disposal of company stock related to tax obligations and vesting of restricted stock units.

Summary

• On March 6, 2024, Christine Chung, SVP of China Operations at FibroGen, engaged in transactions involving FibroGen common stock.
• 23,168 shares were disposed of to cover tax obligations at a price of $1.87 per share.
• 781 shares were acquired due to the vesting of a PSU Milestone Grant.
• 422 shares were disposed of to cover tax obligations related to the vesting of the PSU Milestone Grant, at a price of $1.87.
• Following these transactions, Chung beneficially owns 341,028 shares of FibroGen common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Positives

• The vesting of PSU Milestone Grant resulted in the acquisition of 781 shares, indicating achievement of performance milestones.

Industry Context

This Form 4 filing is a routine disclosure related to insider transactions and provides transparency to investors regarding the stock ownership of FibroGen's executives.

Stakeholder Impact

• The transactions provide transparency to shareholders regarding executive stock ownership.
• The vesting of restricted stock units and PSU Milestone Grant may have a positive impact on employee morale.

Key Dates